Cargando…
Regulation of miR-30b in cancer development, apoptosis, and drug resistance
miR-30b, which is encoded by the gene located on chromosome 8q24.22, plays an important role in a variety of diseases. In most types of tumors, miR-30b significantly inhibits the proliferation, migration, and invasion of cancer cells through the regulation of target genes. Moreover, miR-30b can inhi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886600/ https://www.ncbi.nlm.nih.gov/pubmed/35291564 http://dx.doi.org/10.1515/biol-2022-0017 |
_version_ | 1784660701970694144 |
---|---|
author | Fu, Zhen-Jie Chen, Yan Xu, Yu-Qin Lin, Mei-Ai Wen, Hang Chen, Yi-Tao Pan, Pei-Lei |
author_facet | Fu, Zhen-Jie Chen, Yan Xu, Yu-Qin Lin, Mei-Ai Wen, Hang Chen, Yi-Tao Pan, Pei-Lei |
author_sort | Fu, Zhen-Jie |
collection | PubMed |
description | miR-30b, which is encoded by the gene located on chromosome 8q24.22, plays an important role in a variety of diseases. In most types of tumors, miR-30b significantly inhibits the proliferation, migration, and invasion of cancer cells through the regulation of target genes. Moreover, miR-30b can inhibit the PI3K/AKT signaling pathway through the regulation of EGFR, AKT, Derlin-1, GNA13, SIX1, and other target genes, thus inhibiting the EMT process of tumor cells and promoting apoptosis. In addition, miR-30 plays a significant role in alleviating drug resistance in tumor cells. Although the use of miR-30b as a clinical diagnostic indicator or anticancer drug is still facing great difficulties in the short term, with the deepening of research, the potential application of miR-30b is emerging. |
format | Online Article Text |
id | pubmed-8886600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-88866002022-03-14 Regulation of miR-30b in cancer development, apoptosis, and drug resistance Fu, Zhen-Jie Chen, Yan Xu, Yu-Qin Lin, Mei-Ai Wen, Hang Chen, Yi-Tao Pan, Pei-Lei Open Life Sci Review Article miR-30b, which is encoded by the gene located on chromosome 8q24.22, plays an important role in a variety of diseases. In most types of tumors, miR-30b significantly inhibits the proliferation, migration, and invasion of cancer cells through the regulation of target genes. Moreover, miR-30b can inhibit the PI3K/AKT signaling pathway through the regulation of EGFR, AKT, Derlin-1, GNA13, SIX1, and other target genes, thus inhibiting the EMT process of tumor cells and promoting apoptosis. In addition, miR-30 plays a significant role in alleviating drug resistance in tumor cells. Although the use of miR-30b as a clinical diagnostic indicator or anticancer drug is still facing great difficulties in the short term, with the deepening of research, the potential application of miR-30b is emerging. De Gruyter 2022-02-28 /pmc/articles/PMC8886600/ /pubmed/35291564 http://dx.doi.org/10.1515/biol-2022-0017 Text en © 2022 Zhen-Jie Fu et al., published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. |
spellingShingle | Review Article Fu, Zhen-Jie Chen, Yan Xu, Yu-Qin Lin, Mei-Ai Wen, Hang Chen, Yi-Tao Pan, Pei-Lei Regulation of miR-30b in cancer development, apoptosis, and drug resistance |
title | Regulation of miR-30b in cancer development, apoptosis, and drug resistance |
title_full | Regulation of miR-30b in cancer development, apoptosis, and drug resistance |
title_fullStr | Regulation of miR-30b in cancer development, apoptosis, and drug resistance |
title_full_unstemmed | Regulation of miR-30b in cancer development, apoptosis, and drug resistance |
title_short | Regulation of miR-30b in cancer development, apoptosis, and drug resistance |
title_sort | regulation of mir-30b in cancer development, apoptosis, and drug resistance |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886600/ https://www.ncbi.nlm.nih.gov/pubmed/35291564 http://dx.doi.org/10.1515/biol-2022-0017 |
work_keys_str_mv | AT fuzhenjie regulationofmir30bincancerdevelopmentapoptosisanddrugresistance AT chenyan regulationofmir30bincancerdevelopmentapoptosisanddrugresistance AT xuyuqin regulationofmir30bincancerdevelopmentapoptosisanddrugresistance AT linmeiai regulationofmir30bincancerdevelopmentapoptosisanddrugresistance AT wenhang regulationofmir30bincancerdevelopmentapoptosisanddrugresistance AT chenyitao regulationofmir30bincancerdevelopmentapoptosisanddrugresistance AT panpeilei regulationofmir30bincancerdevelopmentapoptosisanddrugresistance |